Blog

On 10 August 2018, Japanese Astellas Pharma bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders. Midven’s UK Innovation & Science Seed Fund (UKI2S) was the founding investor with follow-on, co-investment from Cambridge Enterprise. Kenji Yasukawa, Ph.D., President and CEO of […]

Midven hosts series of regional investment readiness workshops in 2018 for Midlands entrepreneurs We are excited to build upon our 25-year history investing in early-stage businesses with the management of the new £35m West Midlands equity fund, part of the Midlands Engine Investment Fund (MEIF). As we expand our venture work to invest this £35m […]

  Surjit Kooner, Midven Director and Fund Manager of the Midlands Engine Investment Fund (MEIF), was one of the panellists at the British Business Bank summit on Tuesday 20th March at the Millennium Point in Birmingham. The aim of the discussion was to further introduce attendees to Midven, share our track record and our vision […]